AMNEAL FDA Approval ANDA 215106

ANDA 215106

AMNEAL

FDA Drug Application

Application #215106

Documents

Letter2021-12-20

Application Sponsors

ANDA 215106AMNEAL

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL4MG0DEXAMETHASONEDEXAMETHASONE
002TABLET;ORAL6MG0DEXAMETHASONEDEXAMETHASONE

FDA Submissions

UNKNOWN; ORIG1AP2021-10-14STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

AMNEAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215106
            [companyName] => AMNEAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"DEXAMETHASONE","activeIngredients":"DEXAMETHASONE","strength":"4MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"DEXAMETHASONE","activeIngredients":"DEXAMETHASONE","strength":"6MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/14\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-10-14
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.